Vincent Dupriez holds an engineering degree (1991) and a Ph.D. in agronomic sciences and biological engineering (1997) from the University of Louvain, Belgium. His Ph.D. training was done at the "Christian de Duve Institute of Cellular Pathology" (ICP) and University of Louvain Medical School. He joined Euroscreen (Belgium) in 1998, where his group was in charge of Molecular Biology and Assay Development. In particular, he developed the AequoScreen methodology for High Throughput Screening in internal and collaborative drug discovery programs. He also was project manager for a CCR5 anti-HIV drug discovery program. He joined PerkinElmer in July 2007, following its acquisition of Euroscreen, and worked as an R&D member until December 2011, being involved in internal research and collaborations with external partners like Axxam, LONZA, Corning and TGR Biosciences. In January 2012, he transitioned to new functions in Business Development and Scientific Support for Europe. Since November 2013, Vincent is product manager for the "lites" luminescence reporter gene and cell viability assays, for the "SureFire" cellular phosphoproteins assays, and in Europe for the "Onpoint" custom assay developments and custom labeling businesses. Since 2005, Vincent is also lecturer at the free university of Brussels, for the PHARMED post-graduate lectures in pharmaceutical medicine/drug development sciences and since 2016 for the Clinix post-graduate lectures.